Community Solutions Challenge 2025

The AstraZeneca US ACT on Health Equity Community Investment programs aim to address health disparities in underserved communities by supporting innovative community-based solutions. AstraZeneca US is committed to transforming its approach to improve access, affordability, and health outcomes for patients in disease-affected communities facing barriers to care and opportunity. The ACT on Health Equity initiative, through various funding streams, targets the social, cultural, and linguistic needs of these communities. A key component of this initiative is the Community Solutions Challenge (CSC), launched in 2021. The CSC provides grants to community-based 501(c) nonprofit organizations that prioritize the specific needs of populations historically marginalized in healthcare access. Since its inception, the CSC has awarded over $3.7 million to more than 160 nonprofit programs. In 2025, the CSC will allocate up to $1.5 million to both new and existing programs. The application window for the 2025 CSC cycle will run from June 9 to June 30, 2025. Applicants must submit their proposals through the provided link: https://bit.ly/4kpgC16. Detailed criteria and FAQs are accessible via linked resources on the program’s page. The scope of funding supports programs that address social determinants of health, enhance patient education and engagement, and increase the cultural responsiveness of healthcare services. Previous recipients have included organizations like Mobile Care Chicago, which offers no-cost medical care to low-income children via mobile clinics; Parkland Health Foundation, which works to improve breast cancer screening access for uninsured women in Dallas County; and Union Station Homeless Services, which addresses food insecurity among homeless populations in Northeast Los Angeles. Eligibility for the CSC is limited to community-based 501(c) nonprofit organizations. Eligible programs must demonstrate a clear focus on health equity and meet the social, cultural, and linguistic needs of the target communities. The application process requires submission through the provided link within the designated application window. There is no mention of specific application questions, evaluation criteria, or matching requirements in the provided source. Contact information such as a specific name, email, or phone number is not provided in the source text. Additionally, the broader ACT on Health Equity program includes National Strategic Collaborations (NSC), which has distributed $11.6 million to 40 national organizations since 2021. The AstraZeneca Foundation, a legally separate entity established in 1993, also contributes through strategic grants and capacity-building support. The Foundation reached nearly 40,000 individuals last year with increased access to screenings, healthcare services, and health education. Recent announcements include the awarding of $3.5 million and $3.3 million in grants to improve healthcare access and health equity programming. The ACT on Health Equity initiative is an ongoing effort, with updates and detailed impact reports shared periodically through AstraZeneca’s public communications channels. Applicants are encouraged to review all available materials and meet the June 30, 2025, application deadline for the current CSC funding cycle.